Iovance Biotherapeutics, Inc.
TIL immunotherapy cancer therapies
- B2B
About Iovance Biotherapeutics, Inc.
Develops and delivers tumor infiltrating lymphocyte (TIL) therapies, pioneering a transformational approach to cure cancer by harnessing the immune system.
Key facts
- Industry
- Biotechnology Research
- Company size
- 251–1,000 employees
- Headquarters
- San Carlos, Texas, United States
- Founded
- 2007
- Revenue
- $264MFY2025, publicly reported
- Website
- iovance.com
- linkedin.com/company/iovance
Jobs at Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. at a glance
Iovance Biotherapeutics, Inc. is a B2B company in the Biotechnology Research industry, headquartered in San Carlos, Texas, United States.
Iovance Biotherapeutics, Inc. was founded in 2007.
Iovance Biotherapeutics, Inc. has 251–1,000 employees.
Iovance Biotherapeutics, Inc.'s revenue is $264M (FY2025, publicly reported).
Iovance Biotherapeutics, Inc. is hiring: 1 recent open role, including Associate Director, Digital Experience & AI Production.
Frequently asked questions about Iovance Biotherapeutics, Inc.
What is Iovance Biotherapeutics, Inc.'s revenue?
Iovance Biotherapeutics, Inc.'s revenue is $264M (FY2025, publicly reported).
How many employees does Iovance Biotherapeutics, Inc. have?
Iovance Biotherapeutics, Inc. has 251–1,000 employees.
Where is Iovance Biotherapeutics, Inc. headquartered?
Iovance Biotherapeutics, Inc. is headquartered in San Carlos, Texas, United States.
Selling to companies like Iovance Biotherapeutics, Inc.?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies